IN BRIEF: Angle raises GBP20.0 million to fund FDA approval drive
IN BRIEF: Angle raises GBP20.0 million to fund FDA approval drive
Read moreThu, 29th Aug 2019 09:12
IN BRIEF: Angle raises GBP20.0 million to fund FDA approval drive
Read moreIN BRIEF: Angle to raise GBP20 million through shares placing
Read moreUK shareholder meetings calendar - next 7 days
Read moreTRADING UPDATES: DP Poland sales improve; Braveheart swings to profit
Read moreIN BRIEF: Angle responds to additional information request from US FDA
Read moreTRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets
Read moreTRADING UPDATES: Gamma tips 2021 revenue jump; Smart Metering progress
Read moreIN BRIEF: Angle's Parsortix system gets Italian research boost
Read moreAngle reports wider loss, awaits FDA decision on cancer test equipment
Read moreIN BRIEF: Angle enrolls 200 patients for ovarian cancer test study
Read more(Sharecast News) - Liquid biopsy company Angle announced on Monday that its 200-patient ovarian cancer clinical verification study had completed patient enrolment.
Read moreUK earnings, trading statements calendar - next 7 days
Read more(Sharecast News) - Liquid biopsy company Angle has secured its first large-scale pharma services contract, it announced on Friday.
Read moreTRADING UPDATES: AFC raises GBP36 million; Angle wins service contract
Read moreIN BRIEF: Angle launches clinical services laboratories in UK and US
Read more